
Sunshine Biopharma Inc.
SBFMNasdaqCIK 1402328HealthcareFiscal year ends Dec 31
Reports and events: 194 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2015-06-0112:56 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws | 0001354488-15-002794 |
| 2015-05-0716:30 ET | 10-Q | Quarterly reportPeriod 2015-03-31 | 0001354488-15-002193 |
| 2015-03-1116:23 ET | 10-K | Annual reportPeriod 2014-12-31 | 0001354488-15-001081 |
| 2015-02-2412:43 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001354488-15-000787 |
| 2014-11-1916:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001354488-14-005928 |
| 2014-11-1207:00 ET | 10-Q | Quarterly reportPeriod 2014-09-30 | 0001354488-14-005565 |
| 2014-08-1217:26 ET | 10-Q | Quarterly reportPeriod 2014-06-30 | 0001354488-14-004103 |
| 2014-07-0319:07 ET | S-1/A | Registration statement, amended | 0001354488-14-003530 |
| 2014-05-2216:47 ET | S-1 | Registration statement | 0001354488-14-002936 |
| 2014-05-0912:46 ET | 10-Q | Quarterly reportPeriod 2014-03-31 | 0001354488-14-002379 |
| 2014-04-2816:34 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001354488-14-002090 |
| 2014-03-1916:38 ET | 10-K | Annual reportPeriod 2013-12-31 | 0001354488-14-001275 |
| 2013-11-0416:37 ET | 10-Q | Quarterly reportPeriod 2013-09-30 | 0001354488-13-005974 |
| 2013-08-0611:20 ET | 10-Q | Quarterly reportPeriod 2013-06-30 | 0001354488-13-004212 |
| 2013-05-0912:12 ET | 10-Q | Quarterly reportPeriod 2013-03-31 | 0001354488-13-002516 |
| 2013-03-1513:51 ET | 10-K | Annual reportPeriod 2012-12-31 | 0001354488-13-001224 |
| 2013-02-2513:23 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001354488-13-000853 |
| 2012-11-2914:09 ET | 8-K | 8.01 Other events | 0001354488-12-006249 |
| 2012-11-0816:19 ET | 10-Q | Quarterly reportPeriod 2012-09-30 | 0001354488-12-005637 |
| 2012-08-0808:30 ET | 10-Q | Quarterly reportPeriod 2012-06-30 | 0001354488-12-003912 |
| 2012-05-0813:47 ET | 10-Q | Quarterly reportPeriod 2012-03-31 | 0001354488-12-002208 |
| 2012-03-1912:14 ET | 10-K | Annual reportPeriod 2011-12-31 | 0001354488-12-001221 |
| 2012-02-0713:27 ET | 8-K/A | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001354488-12-000455 |
| 2012-02-0314:37 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001354488-12-000414 |
| 2011-12-2709:13 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001354488-11-005193 |
| 2011-11-0813:50 ET | 10-Q | Quarterly reportPeriod 2011-09-30 | 0001354488-11-004118 |
| 2011-08-0917:11 ET | 10-Q | Quarterly reportPeriod 2011-06-30 | 0001354488-11-002548 |
| 2011-06-1717:01 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001354488-11-001903 |
| 2011-05-1214:20 ET | 10-Q | Quarterly reportPeriod 2011-03-31 | 0001354488-11-001463 |
| 2011-03-3017:02 ET | 10-K | Annual reportPeriod 2010-12-31 | 0001013596-11-000008 |
| 2011-01-2016:16 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013596-11-000005 |
| 2010-11-1211:05 ET | 10-Q | Quarterly reportPeriod 2010-09-30 | 0001013596-10-000102 |
| 2010-08-0418:51 ET | 10-Q | Quarterly reportPeriod 2010-06-30 | 0001013596-10-000075 |
| 2010-06-0318:35 ET | 8-K | 3.02 Unregistered sale of equity | 0001013596-10-000066 |
| 2010-04-3012:56 ET | 10-Q | Quarterly reportPeriod 2010-03-31 | 0001013596-10-000047 |
| 2010-01-2215:46 ET | 8-K | 5.03 Amendment to articles or bylaws | 0001013596-10-000004 |
| 2010-01-1916:21 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.01 Change in control; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013596-10-000003 |
| 2009-12-2214:07 ET | 10-Q | Quarterly reportPeriod 2009-10-31 | 0001013596-09-000044 |
| 2009-11-1818:47 ET | 8-K | 3.02 Unregistered sale of equity | 0001013596-09-000036 |
| 2009-11-0616:40 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001013596-09-000030 |
| 2009-10-3018:16 ET | 10-K | Annual reportPeriod 2009-07-31 | 0001079974-09-000803 |
| 2009-10-2020:38 ET | 8-K | 2.01 Completion of an acquisition or disposition; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013596-09-000019 |
| 2009-06-1516:33 ET | 10-Q | Quarterly reportPeriod 2009-04-30 | 0001079974-09-000441 |
| 2009-03-1613:54 ET | 10-Q | Quarterly reportPeriod 2009-01-31 | 0001079974-09-000119 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:46 ET. Listed shows no prices and gives no investment advice.